Table 1.
Trial identifiera | Acronym | Condition/Tumor type | Study design | Phase | Status |
---|---|---|---|---|---|
NCT01563874 | N/A | Lymphoma | Observational | N/A | Completed |
NCT00407810 | N/A | Metastatic head and neck cancer | Open-label; interventional | II | Completed |
NCT00867334 | NITMEC | Colorectal cancer | Open-label; interventional | II | Completed |
NCT01074814 | Side-Out | Metastatic breast cancer | Open-label; interventional | II/III | Completed |
NCT01919749 | Side-Out 2 | Metastatic breast cancer | Open-label; interventional | II/III | Recruiting |
NCT01042379 | I-SPY 2 | Breast cancer | Open-label; interventional | II | Recruiting |
NCT01023477 | PINC | Breast-ductal carcinoma in situ | Open-label; interventional | I/II | Recruiting |
NCT00798655 | N/A | Head and neck cancer | Open-label; interventional | II | Recruiting |
NCT02159989 | N/A | Metastatic solid tumors | Open-label; interventional | I | Recruiting |
NCT00897650 | N/A | Lung cancer | Observational | N/A | Recruiting |
NCT02133183 | N/A | Adult Glioblastoma | Open-label; interventional | N/A | Recruiting |
Clinicaltrials.gov identifier accessed from http://clinicaltrials.gov, provided by the U.S. National Library of Medicine, as of July 30, 2014.